Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

December 21, 2011

MassBiologics Receives Funding For Drug Trial

The University of Massachusetts Medical School's MassBiologics laboratory has received a milestone payment from pharmaceutical manufacturer Merck. The move comes after the launch of a Phase-III clinical trial of an antibody combination drug used to treat Clostridium difficile, a gastro-intestinal bacterium, according to a UMass Medical School statement.

The drug was developed by MassBiologics and Medarex, a biotechnology division of Bristol Myers Squibb based in Princeton, N.J., and licensed by Merck.

The amount of Merck's payment was not disclosed. Merck intends to file for FDA approval of the drug in 2014, according to a spokesman for UMass Medical School.

Sign up for Enews

WBJ Web Partners

1 Comments

Anonymous
August 1, 2019

Are you looking for a business loan, personal loans, mortgage loans, car loans, student loans, unsecured consolidation loans,project funding etc ... Or simply refuse loan from a bank or financial institution for one or more reasons? We are the right solutions for credit! We offer loans to businesses and individuals with low and affordable interest rate of 2%. So if you are Interested in an urgent and secured loan. For more information kindly email us today Via: elegantloanfirm@hotmail.com.

Order a PDF